Treatment-related osteonecrosis of the jaw: presentation and management
Intended for healthcare professionals
CPD Previous     Next

Treatment-related osteonecrosis of the jaw: presentation and management

Lawrence Drudge-Coates Urology oncology clinical nurse specialist and honorary lecturer, King’s College Hospital NHS Foundation Trust, London
Bruce Turner Uro-oncology nurse practitioner, Homerton University Hospital NHS Foundation Trust, London, and Bart’s Health Trust, London

This article aims to increase nurses’ understanding of resorption inhibitor-associated osteonecrosis of the jaw, a common bone metastasis that can develop following courses of anti-bone resorption therapies. The causes, signs and symptoms, and disease incidence are described. The article discusses prevention strategies, such as maintaining good oral health, and the challenges facing nurses caring for this patient group. The condition can be difficult to eradicate through surgical or medical interventions, and may consequently affect patients’ quality of life, so psychological support is an important component of care.

Cancer Nursing Practice. 11, 5, 28-36. doi: 10.7748/cnp2012.


Peer review

This article has been subject to double blind peer review

Conflict of interest

None declared. A medical writer was used to prepare a literature review

Want to read more?

Already have access? Log in


3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics

Alternatively, you can purchase access to this article for the next seven days. Buy now

Are you a student? Our student subscription has content especially for you.
Find out more